Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 USD | 0.00% | +2.63% | +13.14% |
Apr. 16 | ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 12.51 | 16.29 | 12.03 | 3.271 | 1.885 | 5.408 | - | - |
Enterprise Value (EV) 1 | 12.51 | 16.29 | 12.03 | 3.271 | 1.885 | 5.408 | 5.408 | 5.408 |
P/E ratio | -1.31 x | -0.8 x | -1.05 x | -0.16 x | -0.08 x | 8.5 x | 3.4 x | 2.19 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.96 x | 1.67 x | 1.29 x | 0.31 x | 0.2 x | 0.32 x | 0.26 x | 0.22 x |
EV / Revenue | 0.96 x | 1.67 x | 1.29 x | 0.31 x | 0.2 x | 0.32 x | 0.26 x | 0.22 x |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 63.2 | 173 | 265 | 1,022 | 3,137 | 7,953 | - | - |
Reference price 2 | 198.0 | 94.05 | 45.45 | 3.200 | 0.6010 | 0.6800 | 0.6800 | 0.6800 |
Announcement Date | 3/24/20 | 3/17/21 | 3/28/22 | 3/30/23 | 4/16/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 13.05 | 9.744 | 9.294 | 10.48 | 9.445 | 16.86 | 21.11 | 24.61 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -4.733 | -8.895 | -7.231 | -6.193 | -6.574 | 2.029 | 5.094 | 7.98 |
Operating Margin | -36.28% | -91.29% | -77.8% | -59.08% | -69.6% | 12.04% | 24.14% | 32.43% |
Earnings before Tax (EBT) 1 | -10.1 | -16.81 | -11.88 | -11.81 | -18.92 | 2.07 | 5.165 | 8.113 |
Net income 1 | -9.497 | -16.35 | -11.38 | -11.27 | -17.98 | 2.07 | 5.165 | 8.113 |
Net margin | -72.79% | -167.81% | -122.43% | -107.51% | -190.31% | 12.28% | 24.47% | 32.97% |
EPS 2 | -151.2 | -117.0 | -43.20 | -20.45 | -7.590 | 0.0800 | 0.2000 | 0.3100 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/24/20 | 3/17/21 | 3/28/22 | 3/30/23 | 4/16/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 3.158 | 2.418 | 2.663 | - | 2.115 | 2.676 | 2.572 | 2.273 | 2.194 | 2.406 | 3.8 | 4.1 | 4.3 | 4.6 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT | -1.105 | -1.325 | - | - | -2.015 | -1.527 | - | -1.73 | - | -2.242 | - | - | - | - |
Operating Margin | -34.99% | -54.8% | - | - | -95.27% | -57.06% | - | -76.11% | - | -93.18% | - | - | - | - |
Earnings before Tax (EBT) | -1.792 | -2.886 | - | - | -3.403 | -3.573 | - | -2.398 | - | -7.599 | - | - | - | - |
Net income | -1.774 | -2.654 | - | -2.688 | -3.24 | -3.433 | - | -2.26 | - | -7.014 | - | - | - | - |
Net margin | -56.17% | -109.76% | - | - | -153.19% | -128.29% | - | -99.43% | - | -291.52% | - | - | - | - |
EPS 2 | -6.750 | -9.900 | -7.200 | -9.000 | -4.500 | -3.310 | -4.070 | -0.9100 | -1.440 | -2.330 | 0.0100 | 0.0200 | 0.0200 | 0.0300 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/12/21 | 3/28/22 | 5/20/22 | 8/11/22 | 11/10/22 | 3/30/23 | 5/15/23 | 8/10/23 | 11/13/23 | 4/16/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 3/24/20 | 3/17/21 | 3/28/22 | 3/30/23 | 4/16/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.14% | 5.41M | |
+7.13% | 7.91B | |
-3.15% | 4.66B | |
-9.18% | 2.84B | |
+1.11% | 2.03B | |
-26.56% | 1.12B | |
-11.09% | 816M | |
-13.49% | 755M | |
-22.71% | 759M | |
-56.85% | 682M |
- Stock Market
- Equities
- THMO Stock
- Financials ThermoGenesis Holdings, Inc.